工程矩阵无药物蛋白纳米颗粒有望穿透生物障碍物治疗角膜新血管化的治疗
Hongyan Xu1,2, Bangxun Mao3, Shulan Ni1,2
1Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai 317000, People's Republic of China.
ACS nano
|March 7, 2024
概括
研究人员使用离子开发了一种新的蛋白质纳米粒子 (NP) 策略,以改善药物输送. 这种方法提高了蛋白质药物的透性和稳定性,有效治疗角膜新血管化.
科学领域:
- 生物材料科学 生物材料科学
- 药物运输 药物运输 药物运输
- 眼科医生 眼科 眼科
背景情况:
- 蛋白质药物具有很高的特异性,但面临着诸如透性和降解性差等挑战.
- 现有的输送系统通常需要复杂的蛋白质封装协议.
研究的目的:
- 开发一种简单且通用的策略,用于制造具有增强性质的蛋白质纳米粒子 (NP).
- 改善蛋白质药物的眼部输送和治疗效果,特别是贝瓦西祖马布 (Beva).
主要方法:
- 采用了一个自由捕获矩阵策略,将贝瓦齐祖马布与离子混合,形成Beva-NPs.
- 该策略在使用不同的金属离子对各种蛋白质NP进行了验证.
- 使用聚胺胺树脂聚合物 (G4) 的现场兴奋剂用于增强眼睛的保留和透.
主要成果:
- 在Beva-NPs.中,实现了高负载效率 (99.2%±0.41%).
- 贝瓦-G4-NPs通过跨细胞和细胞通路展示了延长的眼睛保留和透.
- 观察到角膜新血管化 (CNV) 的显著抑制,在大鼠模型中从91.6%降至13.5%.
结论:
- 离子介导的蛋白质NP形成是一种通用和有效的策略.
- 这种方法克服了蛋白质药物的关键局限性,包括透性和稳定性差.
- 工程蛋白NP显示出改善治疗结果的承诺在诸如CNV等眼部疾病中.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...


